Good news to start the day with! Ok it's just one patient...
PSA Undetectable in First Patient Wit... - Advanced Prostate...
PSA Undetectable in First Patient With mCRPC Given Cu-67 SAR-bisPSMA
![Maxone73 profile image](https://images.hu-production.be/avatars/cc6cfcd066d747309f3dc14136bd6475_small@2x_100x100.jpg)
Written by
![Maxone73 profile image](https://images.hu-production.be/avatars/cc6cfcd066d747309f3dc14136bd6475_small@2x_100x100.jpg)
Maxone73
To view profiles and participate in discussions please or .
Read more about...
5 Replies
•
it’s a good start
Thumbs up
I like the EAP mention. Good to see it being used and yielding a good outcome.
Well, I'm sure that patient is happy! So why couldn't we be the same, for him, or possibly others going forward!
Not what you're looking for?
You may also like...
Some good news to start the day: Complete Response in First Patient Ever Treated with 2 Doses of Cu-67 SAR-bisPSMA at 8GBq...6 months
so...
\\"The patient remains with undetectable levels of Prostate Specific Antigen (PSA) for...
Have we discussed this new Australian Theranostic? Clarity’s CU-65/CU-67 bisPSMA. Maybe some of the smarter guys here may be up on it?
https://www.biospace.com/article/releases/first-patient-treated-in-clarity-s-cu-64-cu-67-sar-bispsma
64Cu-SAR-bisPSMA Is Safe and Highly Effective in Detecting Tumours in Prostate Cancer Patients: results from COBRA trial
ty-s-sar-bispsma-is-safe-and-highly-effective-in-detecting-tumours-in-prostate-cancer-patients-phase
PHASE 3 ECLIPSE STUDY FOR (MCRPC) PATIENTS- FIRST INFUSION OF Lutetium- 177
scan it was obvious I was MCRPC.
MO recommended me for Eclipse Trial, started at St. Louis U's...
Lu 177 PSMA vs Cabazitaxel (Jevtana) in patients with mCRPC previously treated with Docetaxel and with a progressing PSA with values >/=20.
More patients had a =/>50% decrease in the PSA when treated with Lu 177 PSMA than patients...